Table 4.

Management strategies

	Low risk (n = 163)	Intermediate risk (n = 256)	High risk (n = 10)
Anticoagulation alone	148 (90.8%)	239 (93.4%)	0
Supportive care only	4 (2.4%)	2 (0.8%)	0
First inpatient anticoagulant used (% of anticoagulated)
Unfractionated heparin	116 (73%)	211 (83%)	10 (100%)
Low molecular weight heparin (Enoxaparin)	35 (22%)	34 (13%)	0
Apixaban	5 (3.1%)	6 (2.4%)	0
Rivaroxaban	2 (1.3%)	0	0
Warfarin	0	2 (0.8%)	0
Bivalirudin	1 (0.6%)	0	0
Argatroban	0	1 (0.4%)	0
Anticoagulation plus advanced therapies (% of all cases)
50 mg rTPA	0	3 (1.2%)	4 (40%)
100 mg rTPA	0	1 (0.4%)	5 (50%)
Catheter directed thrombolysis	0	1 (0.4%)	1 (10%)
Mechanical thrombectomy	0	1 (0.4%)	0
IVC filter	11 (6.7%)	9 (3.5%)	3 (30%)
VA-ECMO	0	0	3 (30%)